News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
111 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (221)
2 (198)
3 (246)
4 (134)
5 (2)
6 (26)
7 (189)
8 (263)
9 (229)
10 (265)
11 (138)
12 (2)
13 (5)
14 (238)
15 (260)
16 (218)
17 (239)
18 (111)
19 (1)
20 (3)
21 (103)
22 (312)
23 (250)
24 (321)
25 (115)
26 (6)
27 (5)
28 (328)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
Drug Development
Sanofi, Regeneron Suffer Rare Dupixent Flop in CSU
After roaring into February with positive data in five different indications, Regeneron and Sanofi announced today a late-stage Dupixent trial has been halted due to futility.
February 18, 2022
·
2 min read
·
Alex Keown
Pharm Country
Covid-19: A Vision for the “New Normal” and Pfizer’s Paxlovid
Two-plus years into the pandemic, it’s obvious that COVID-19 isn’t going away, prompting discussion about what this “new normal” will actually look like.
February 18, 2022
·
5 min read
·
Mark Terry
Global Retractable Safety Syringe Market Key Development and Growth Dynamics [Industry Analysis Report]
Needlesticks have been key cause of sharps injuries to healthcare workers and consequently exposing them to blood-borne pathogens.
February 18, 2022
·
6 min read
Non-insulin Anti-diabetes Drugs Market: The SGLT-2 Inhibitors Segment is Expected to Witness Strong Growth
Diabetes is a metabolic disease, wherein the body is either unable to secret insulin or is unable to utilize the generated insulin.
February 18, 2022
·
5 min read
Moist Wound Dressings Market: Diabetic foot ulcers is projected to dominate the market
Innovations in advanced wound care dressings have changed the paradigm of health care standards since the last decade.
February 18, 2022
·
5 min read
Metabolic Disorders Market: The diabetes segment, is expected to register high growth during the forecast period
Metabolism is a process through which food is broken-down into sugars and acids in the body.
February 18, 2022
·
5 min read
Lip Fillers Market [Key drivers | Restraints | Opportunity | Challenges] – Detailed Industry Analysis Report
Inclination towards maintaining physique and working in improving physical attributes has increased significantly across the globe.
February 18, 2022
·
6 min read
Oscillating Positive Expiratory Pressure (OPEP) Devices Market Demand Growth Analysis - Technological Advancements
Keeping in mind the development of the healthcare sector across both developed as well as developing countries, the global oscillating positive expiratory pressure devices market is expected to witness a steady growth in the coming years of the forecast period.
February 18, 2022
·
6 min read
Non-steroidal Anti-inflammatory Drugs Market: The Injectable Segment is Expected to Witness Rapid Growth Owing to Higher Efficacy
Non-steroidal anti-inflammatory drugs is a class of powerful analgesics, distinguished by their non-steroidal chemical structure.
February 18, 2022
·
5 min read
Giardiasis Treatment Market: Nitazoxanide is Projected to Dominate the Market During the Forecast Period
Giardiasis is a bowel infection caused by microscopic parasite known as Giardia lamblia or Giardia intestinalis.
February 18, 2022
·
5 min read
Previous
2 of 12
Next